Literature DB >> 14534060

Experiencing the loss of mobility: perspectives of older adults with MS.

Marcia Finlayson1, Toni van Denend.   

Abstract

PURPOSE: The purpose of this study was to develop an understanding the experience and meaning of mobility loss among older adults with multiple sclerosis (MS). This work is part of a larger study on the health concerns and service needs of older adults with MS.
METHODS: Twenty-seven people with MS (mean age = 62 years, range = 55-82) were interviewed using a phenomenological approach.
RESULTS: Thematic analysis found that three factors contributed to participants' experience of mobility as a person with MS: reality of having MS, mobility needs, and contextual factors. Participants discussed how the reality of MS meant variability in their ability to get around and the importance of trying to remain in control over their mobility experiences. The experience of mobility lead participants to mourn losses, take action, and contemplate their futures. They expressed concerns about the continual declines in their mobility, losing independence, becoming a burden on caregivers, and the potential for having to move into a nursing home.
CONCLUSIONS: Findings provide insight into the experience of mobility loss among older adults with MS, and point to potential strategies that can be used to help people cope with and adapt to these losses.

Entities:  

Mesh:

Year:  2003        PMID: 14534060     DOI: 10.1080/09638280310001596180

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  13 in total

1.  Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners.

Authors:  Nicholas G Larocca
Journal:  Patient       Date:  2011       Impact factor: 3.883

2.  Perspectives on Aging-Related Preparation.

Authors:  Silvia Sörensen; Rachel L Missell; Alexander Eustice-Corwin; Dorine A Otieno
Journal:  J Elder Policy       Date:  2021

3.  Use of cognitive aids and other assistive technology by individuals with multiple sclerosis.

Authors:  Kurt L Johnson; Alyssa M Bamer; Kathryn M Yorkston; Dagmar Amtmann
Journal:  Disabil Rehabil Assist Technol       Date:  2009-01

4.  Exploring physical activity behaviour of persons with multiple sclerosis: a qualitative pilot study.

Authors:  Matthew A Plow; Linda Resnik; Susan M Allen
Journal:  Disabil Rehabil       Date:  2009       Impact factor: 3.033

5.  Feasibility of the Enhancing Participation In the Community by improving Wheelchair Skills (EPIC Wheels) program: study protocol for a randomized controlled trial.

Authors:  Edward M Giesbrecht; William C Miller; Janice J Eng; Ian M Mitchell; Roberta L Woodgate; Charles H Goldsmith
Journal:  Trials       Date:  2013-10-24       Impact factor: 2.279

6.  Adherence to Physiotherapy-Guided Web-Based Exercise for Persons with Moderate-to-Severe Multiple Sclerosis: A Randomized Controlled Pilot Study.

Authors:  Sarah J Donkers; Darren Nickel; Lorna Paul; Shyane R Wiegers; Katherine B Knox
Journal:  Int J MS Care       Date:  2020-01-08

7.  Navigating uncharted territory: a qualitative study of the experience of transitioning to wheelchair use among older adults and their care providers.

Authors:  Edward M Giesbrecht; William C Miller; Roberta L Woodgate
Journal:  BMC Geriatr       Date:  2015-07-28       Impact factor: 3.921

8.  Evaluation of an intelligent wheelchair system for older adults with cognitive impairments.

Authors:  Tuck-Voon How; Rosalie H Wang; Alex Mihailidis
Journal:  J Neuroeng Rehabil       Date:  2013-08-07       Impact factor: 4.262

9.  Levels and Rates of Physical Activity in Older Adults with Multiple Sclerosis.

Authors:  Rachel E Klaren; Emerson Sebastiao; Chung-Yi Chiu; Dominique Kinnett-Hopkins; Edward McAuley; Robert W Motl
Journal:  Aging Dis       Date:  2016-05-27       Impact factor: 6.745

10.  Falls in people with multiple sclerosis: experiences of 115 fall situations.

Authors:  Anna Carling; Anette Forsberg; Ylva Nilsagård
Journal:  Clin Rehabil       Date:  2017-09-13       Impact factor: 3.477

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.